ArticleInternational journal of inflammation2010
The bowel microbiota and inflammatory bowel diseases.
Article in International journal of inflammation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Alleviation of DSS-induced colitis in mice by a new-isolatedFrontiers in microbiology · 2023Article
- Dextran Sulphate Sodium Acute Colitis Rat Model: A Suitable Tool for Advancing Our Understanding of Immune and Microbial Mechanisms in the Pathogenesis of Inflammatory Bowel Disease.Veterinary sciences · 2022Article
- Nutrigenomics and Nutrigenetics Research in New Zealand, and Its Relevance and Application to Gastrointestinal Health.Nutrients · 2022Review
- Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases.Journal of clinical medicine · 2021Review
- Proinflammatory Sulfur-Reducing Bacteria Are More Abundant in Colonic Biopsies of Patients with Microscopic Colitis Compared to Healthy Controls.Digestive diseases and sciences · 2019Article
- PROBIOTICS - A PROBABLE THERAPEUTIC AGENT FOR SPONDYLOARTHROPATHY.International journal of probiotics & prebiotics · 2017Article
- Isolation and identification of quercetin degrading bacteria from human fecal microbes.PloS one · 2014Article
- In vitro catabolism of quercetin by human fecal bacteria and the antioxidant capacity of its catabolites.Food & nutrition research · 2014Article
- Fecal microbiota transplantation: indications, methods, evidence, and future directions.Current gastroenterology reports · 2013Review
- Altered gut microbiota promotes colitis-associated cancer in IL-1 receptor-associated kinase M-deficient mice.Inflammatory bowel diseases · 2013Article
- Gut microbiota, probiotics, and human health.Bioscience of microbiota, food and health · 2013Review
- The transition of acute to chronic bowel inflammation in spondyloarthritis.Nature reviews. Rheumatology · 2012Review
- The role of bacteria in the pathogenesis of ulcerative colitis.Journal of signal transduction · 2012Article
- Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome.Arthritis and rheumatism · 2011Article
- Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitis.PloS one · 2011Article
- Association of oral manifestations in ulcerative colitis: A pilot study.Journal of oral and maxillofacial pathology : JOMFPArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human bowel contains a large and biodiverse bacterial community known as the microbiota or microbiome. It seems likely that the microbiota, fractions of the microbiota, or specific species comprising the microbiota provide the antigenic fuel that drives the chronic immune inflammation of the bowel mucosa that is characteristic of Crohn's disease and ulcerative colitis. At least twenty years of microbiological research have been expended on analysis of the composition of the bowel microbiota of inflammatory bowel disease patients in comparison to that of control subjects. Despite extensive speculations about the aetiological role of dysbiosis in inflammatory bowel diseases, knowledge that can be easily translated into effective remedies for patients has not eventuated. The causes of this failure may be due to poorly defined and executed bacteriological studies, as well as the overwhelming complexity of a biome that contains hundreds of bacterial species and trillions of bacterial cells.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.